Robson PJ - Search Results

1

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.

Nicholson AN, Turner C, Stone BM, Robson PJ. Nicholson AN, et al. Among authors: robson pj. J Clin Psychopharmacol. 2004 Jun;24(3):305-13. doi: 10.1097/01.jcp.0000125688.05091.8f. J Clin Psychopharmacol. 2004. PMID: 15118485 Clinical Trial.

2

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Blake DR, et al. Rheumatology (Oxford). 2006 Jan;45(1):50-2. doi: 10.1093/rheumatology/kei183. Epub 2005 Nov 9. Rheumatology (Oxford). 2006. PMID: 16282192 Clinical Trial.

3

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.

Robson P. Robson P. Expert Opin Drug Saf. 2011 Sep;10(5):675-85. doi: 10.1517/14740338.2011.575778. Epub 2011 May 4. Expert Opin Drug Saf. 2011. PMID: 21542664 Review.

4

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.

Wade DT, Robson P, House H, Makela P, Aram J. Wade DT, et al. Clin Rehabil. 2003 Feb;17(1):21-9. doi: 10.1191/0269215503cr581oa. Clin Rehabil. 2003. PMID: 12617376 Clinical Trial.

5

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Wade DT, Makela P, Robson P, House H, Bateman C. Wade DT, et al. Mult Scler. 2004 Aug;10(4):434-41. doi: 10.1191/1352458504ms1082oa. Mult Scler. 2004. PMID: 15327042 Clinical Trial.

6

Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.

Russo EB, Guy GW, Robson PJ. Russo EB, et al. Among authors: robson pj. Chem Biodivers. 2007 Aug;4(8):1729-43. doi: 10.1002/cbdv.200790150. Chem Biodivers. 2007. PMID: 17712817 Review.

7

Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.

Tomida I, Azuara-Blanco A, House H, Flint M, Pertwee RG, Robson PJ. Tomida I, et al. Among authors: robson pj. J Glaucoma. 2006 Oct;15(5):349-53. doi: 10.1097/01.ijg.0000212260.04488.60. J Glaucoma. 2006. PMID: 16988594 Clinical Trial.

8

Therapeutic potential of cannabinoid medicines.

Robson PJ. Robson PJ. Drug Test Anal. 2014 Jan-Feb;6(1-2):24-30. doi: 10.1002/dta.1529. Epub 2013 Sep 4. Drug Test Anal. 2014. PMID: 24006213 Review.

9

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

McGuire P, Robson P, Cubala WJ, Vasile D, Morrison PD, Barron R, Taylor A, Wright S. McGuire P, et al. Am J Psychiatry. 2018 Mar 1;175(3):225-231. doi: 10.1176/appi.ajp.2017.17030325. Epub 2017 Dec 15. Am J Psychiatry. 2018. PMID: 29241357 Clinical Trial.

10

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.

Wade DT, Makela PM, House H, Bateman C, Robson P. Wade DT, et al. Mult Scler. 2006 Oct;12(5):639-45. doi: 10.1177/1352458505070618. Mult Scler. 2006. PMID: 17086911 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results